STOCK TITAN

Bruker Corporation - BRKR STOCK NEWS

Welcome to our dedicated page for Bruker Corporation news (Ticker: BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker Corporation stock.

Bruker Corporation (symbol: BRKR) stands as a global leader in analytical instrumentation. With over fifty years of innovation, Bruker aims to provide top-tier technological solutions for various analytical tasks. Headquartered in Massachusetts, USA, Bruker employs more than 6,500 individuals across 90 locations worldwide.

The company's operations are categorized into four main segments:

  • BSI BioSpin: Specializes in magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.
  • BSI CALID: Focuses on mass spectrometry, chromatography, molecular spectroscopy, and in vitro diagnostics.
  • BSI Nano: Offers solutions in X-ray diffraction, elemental analysis, atomic force microscopy, and surface and dimensional metrology.
  • Bruker Energy & Supercon Technologies (BEST): Provides superconducting materials and devices for energy, science, and healthcare sectors.

Bruker demonstrates a strong commitment to research and development, continuously expanding its suite of products and maintaining a robust installed base globally. The company’s dedication to quality and reliability is reflected in its significant presence in the Asia Pacific region, which accounts for the largest share of its revenue.

Recent achievements include advancements in mass spectrometry and collaborations with leading pharmaceutical and biotechnology companies. Bruker's technologies are vital for quality assurance in industrial production processes, supporting customers in ensuring precision and reliability.

Bruker Corporation is not just a manufacturer but a partner in innovation, helping scientists and researchers address complex analytical challenges with integrity and cutting-edge technology.

Rhea-AI Summary
Bruker Corporation reports Q3 2023 revenues of $742.8 million, up 16.3% YoY. Organic revenue growth is 10.9% YoY. Q3 2023 GAAP EPS is $0.60, non-GAAP EPS is $0.74, up 12.1% YoY. FY 2023 revenue guidance increased to $2.88-$2.91 billion, implying reported revenue growth of 14%-15% YoY and organic revenue growth of 11.5%-12.5% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) will report Q3 2023 financial results on November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
-
Rhea-AI Summary
Bruker Corporation has made a majority investment in MIRO Analytical AG, a provider of fast, compact Quantum Cascade Laser (QCL)-based multi-gas analyzers. MIRO anticipates 2023 revenue of approximately $2.5 million and expects rapid growth in the high-precision trace gas analysis market. The financial details of the transaction were not disclosed. MIRO's products complement Bruker's gas analyzers and will contribute to advancing climate research and environmental pollution analysis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.73%
Tags
none
News
Rhea-AI Summary
Bruker Corporation completes acquisition of PhenomeX for $108 million in cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
-
Rhea-AI Summary
Bruker Corporation announces the release of the Hysitron TI 990 TriboIndenter, bringing superior levels of performance, automation, and productivity to nanomechanical testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
none
-
Rhea-AI Summary
Bruker Corporation announces advances in instrumental methods, consumables, and software for 4D-Proteomics, MALDI HiPLEX-IHC spatial tissue proteomics, 4D-Lipidomics, and 4D-Metabolomics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.14%
Tags
none
Rhea-AI Summary
Fraport AG has chosen Bruker to provide up to 220 DE-tector flex explosives and narcotics trace detectors to modernize passenger security at Frankfurt Airport. The installations will take place from 2023 to 2027. The new systems are certified and will replace older detectors, ensuring the safety and security of passengers and the aviation industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
none
-
Rhea-AI Summary
Bruker Corporation initiates cash tender offer to acquire PhenomeX Inc. for $1.00 per share
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
-
Rhea-AI Summary
Bruker Corporation to participate in the Morgan Stanley Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
Rhea-AI Summary
Bruker Corporation is set to acquire PhenomeX Inc. for $1.00 per share in an all-cash transaction, valuing PhenomeX at approximately $108 million. PhenomeX is a functional cell biology company that provides single-cell biology research tools. The acquisition will mark Bruker's entry into single-cell biology research tools, complementing their spatial biology business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.55%
Tags

FAQ

What is the current stock price of Bruker Corporation (BRKR)?

The current stock price of Bruker Corporation (BRKR) is $57 as of December 20, 2024.

What is the market cap of Bruker Corporation (BRKR)?

The market cap of Bruker Corporation (BRKR) is approximately 8.7B.

What does Bruker Corporation specialize in?

Bruker Corporation specializes in analytical instrumentation, offering solutions in magnetic resonance, mass spectrometry, X-ray analysis, and superconducting technologies.

How is Bruker Corporation structured?

Bruker operates in four main segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST).

Where does Bruker generate most of its revenue?

The majority of Bruker's revenue is generated from the Asia Pacific region.

How many employees does Bruker Corporation have?

Bruker Corporation employs over 6,500 people globally.

What industries does Bruker serve?

Bruker serves the life sciences, pharmaceutical, biotechnology, and industrial production sectors.

What recent advancements has Bruker made?

Bruker has made significant advancements in mass spectrometry and has formed key partnerships with leading pharmaceutical and biotechnology firms.

What is BSI BioSpin known for?

BSI BioSpin is known for its magnetic resonance technologies, including NMR, EPR, and preclinical MRI systems.

Why are Bruker's technologies important in industrial production?

Bruker's instruments ensure quality and process reliability, which are critical for precision and performance in industrial production.

What is the BEST segment of Bruker Corporation?

BEST, or Bruker Energy & Supercon Technologies, provides superconducting materials and devices for the energy, science, and healthcare sectors.

How does Bruker Corporation contribute to scientific research?

Bruker develops state-of-the-art technologies that assist scientists and researchers in addressing complex analytical questions with precision.

Bruker Corporation

Nasdaq:BRKR

BRKR Rankings

BRKR Stock Data

8.72B
103.19M
31.92%
79.77%
1.99%
Medical Devices
Laboratory Analytical Instruments
Link
United States of America
BILLERICA